Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sigea
Trieste, Friuli Venezia Giulia, Italy
- Ownership
- Private
- Development stage
- Other
01
Overview
Sigea was a University of Trieste spin-off specializing in biopolymers and macromolecules, notably contributing the Hyaluromimethic platform for biomaterials, later integrated into BMG Pharma's injectables pipeline focused on aesthetic medicine, oral care, and osteoarthritis.[1][5]
- Therapeutic areas
- OtherDermatologyRheumatology
- Modalities
- BiologicBiopolymer
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Sigea.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sigea.